Humira Drug Sales & Forecast

Humira (adalimumab) is a biologic therapy administered as a subcutaneous injection. It is approved to treat the following autoimmune diseases such as rheumatology, gastroenterology, dermatology and ophthalmology in the United States, Canada and Mexico (collectively, North America) and in the European Union. MNG Tracker report title “Humira Drug Sales & Forecast” provides historical as well as estimated Humira sales in Global, United States and Rest of the world (International) market. This is single page report which also covered key factors for the growth/decline of the Humira sales in Global, United States and Rest of the world (International) market.